Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Gap Up - Still a Buy?

Key Points

• Bayer Aktiengesellschaft's shares opened at $8.27, up from a previous close of $7.74, indicating a positive market movement.
• Analysts have varied ratings on Bayer, with Hsbc Global Res and Goldman Sachs upgrading their ratings to "strong-buy," while others have rated it as "hold."
• The company's latest earnings report showed $0.65 earnings per share, beating expectations and revealing a revenue of $15.27 billion for the quarter.

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $7.74, but opened at $8.27. Bayer Aktiengesellschaft shares last traded at $8.23, with a volume of 133,334 shares trading hands.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on BAYRY shares. Wall Street Zen downgraded shares of Bayer Aktiengesellschaft from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th. The Goldman Sachs Group upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Hsbc Global Res upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, June 11th. Finally, Kepler Capital Markets upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research note on Wednesday, June 11th. Two equities research analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Bayer Aktiengesellschaft has a consensus rating of "Buy".

Bayer Aktiengesellschaft Stock Up 4.5%

The company's 50 day moving average price is $7.77 and its 200 day moving average price is $6.67. The company has a quick ratio of 0.79, a current ratio of 1.25 and a debt-to-equity ratio of 1.07. The firm has a market capitalization of $31.79 billion, a price-to-earnings ratio of -8.79 and a beta of 0.91.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.63 by $0.02. Bayer Aktiengesellschaft had a negative net margin of 7.26% and a positive return on equity of 13.94%. The business had revenue of $15.27 billion during the quarter, compared to the consensus estimate of $13.39 billion. As a group, research analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.